Nektar Therapeutics (NKTR) recent quarterly performance of 173.11% is not showing the real picture
Witnessing the stock’s movement on the chart, on Wednesday Nektar Therapeutics (NASDAQ: NKTR) had a quiet start as it plunged -2.82% to $1.38, before settling